Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Virology

• Publication date

  2011-02-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2010.10.033PMID 21084104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

  2010cited by this paper
• Safety and Pharmacokinetics of Single Intravenous Dose of MGAWN1, a Novel Monoclonal Antibody to West Nile Virus

  2010cited by this paper
• Immature Dengue Virus: A Veiled Pathogen?

  2010cited by this paper
• Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

  2010cited by this paper
• Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

  2010cited by this paper
• The First Human Epitope Map of the Alphaviral E1 and E2 Proteins Reveals a New E2 Epitope with Significant Virus Neutralizing Activity

  2010cited by this paper
• Development of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus Antibodies

  2009cited by this paper
• Tyrosine 78 of premembrane protein is essential for assembly of West Nile virus.

  2009cited by this paper
• Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody

  2009cited by this paper
• Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fusion

  2009cited by this paper
• Solution structure and neutralizing antibody binding studies of domain III of the dengue‐2 virus envelope protein

  2008cited by this paper
• A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen

  2008cited by this paper
• Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus

  2008cited by this paper
• Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

  2008cited by this paper
• Fully human antibodies from transgenic mouse and phage display platforms.

  2008cited by this paper
• The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation

  2008influential reference
• A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles.

  2007cited by this paper
• The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.

  2007cited by this paper
• Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein.

  2007cited by this paper
• Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge.

  2006cited by this paper
• A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus.

  2006cited by this paper
• The Dual-Specific Binding of Dengue Virus and Target Cells for the Antibody-Dependent Enhancement of Dengue Virus Infection1

  2006cited by this paper
• Histidine at Residue 99 and the Transmembrane Region of the Precursor Membrane prM Protein Are Important for the prM-E Heterodimeric Complex Formation of Japanese Encephalitis Virus

  2005cited by this paper
• Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

  2005cited by this paper
• Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.

  2005cited by this paper
• Design of humanized antibodies: from anti-Tac to Zenapax.

  2005cited by this paper
• An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.

  2004cited by this paper
• Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

  2004cited by this paper
• Alterations of pr-M Cleavage and Virus Export in pr-M Junction Chimeric Dengue Viruses

  2004cited by this paper
• Noninfectious Recombinant Antigen for Detection of St. Louis Encephalitis Virus-Specific Antibodies in Serum by Enzyme-Linked Immunosorbent Assay

  2004cited by this paper
• An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

  2004cited by this paper
• Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

  2004cited by this paper
• Immune response to synthetic peptides of dengue prM protein.

  2002cited by this paper
• Isolation of Native Human Monoclonal Autoantibodies to Breast Cancer

  2002cited by this paper
• Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes

  2002influential reference
• A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.

  2001cited by this paper
• West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

  2001influential reference
• Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine

  2000cited by this paper
• Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

  1996cited by this paper
• Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors

  1995cited by this paper
• Dengue virus premembrane and membrane proteins elicit a protective immune response.

  1991cited by this paper
• Acidotropic amines inhibit proteolytic processing of flavivirus prM protein.

  1990cited by this paper
• Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.

  1989cited by this paper
• Structural proteins of La Crosse virus

  1976cited by this paper

• A Scoping Review of Preclinical Research on Monoclonal Antibody Development for Prophylaxis and Treatment of West Nile Virus Infections

  2025influential citation
• Development of Antibody-Based Therapeutics Against West Nile Virus in Plants.

  2023cites this paper
• Monoclonal antibodies to Cache Valley virus for serological diagnosis

  2022cites this paper
• Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus

  2021cites this paper
• Production and Biomedical Application of Flavivirus-like Particles.

  2019cites this paper
• The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis

  2017cites this paper
• Monoclonal antibody against Saint Louis encephalitis prM viral protein.

  2015cites this paper
• Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies

  2015cites this paper
• B Cell Response and Mechanisms of Antibody Protection to West Nile Virus

  2014cites this paper
• Combined Effects of the Structural Heterogeneity and Dynamics of Flaviviruses on Antibody Recognition

  2014cites this paper
• Mechanism and Significance of Cell Type-Dependent Neutralization of Flaviviruses

  2014cites this paper
• A new competitive ELISA detects West Nile virus infection using monoclonal antibodies against the precursor-membrane protein of West Nile virus.

  2013cites this paper
• Degrees of maturity: the complex structure and biology of flaviviruses.

  2012cites this paper
• A Novel Approach for the Rapid Mutagenesis and Directed Evolution of the Structural Genes of West Nile Virus

  2012cites this paper
• Mutations in the West Nile prM protein affect VLP and virion secretion in vitro.

  2012cites this paper
• prM-antibody renders immature West Nile virus infectious in vivo.

  2011cites this paper
• Functional importance of flavivirus maturation

  2011cites this paper
• The role of antibodies in controlling flavivirus cell entry

  2011cites this paper